VEGFA and breast cancer: The level of VEGF, which is also induced under hypoxic conditions (Wykoff et al, 2000; Lal et al, 2001), predicts relapse in patients with breast cancer receiving adjuvant endocrine therapy more significantly than after polychemotherapy (Gasparini et al, 1999; Linderholm et al, 2000).